GHENT, Belgium, Sept. 4, 2024 /PRNewswire/ -- Clouds of Care, a leading MedTech company dedicated to enabling better care for people with...
Phesi's Trial Accelerator™ Platform empowers trial sponsors to make informed decisions swiftly, expediting drug development timelines while upholding the highest...
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the...
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on...
Research organization has been active SCRS member since 2022 founding DURHAM, N.C., Sept. 4, 2024 /PRNewswire/ -- Clinical research organization...
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life...
BEIJING, Sept. 4, 2024 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated...
NAPLES, FL / ACCESSWIRE / September 4, 2024 / ("STEK") Stemtech Corporation, the pioneer and trailblazer in the stem cell...
MIAMI, FL / ACCESSWIRE / September 4, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company...
ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second...
Chairman of Therma Bright's Strategic Investment Partner Recognized for Outstanding Research and Discovery in Respiratory Drug DeliveryToronto, Ontario--(Newsfile Corp. -...
Patients Using the CureSight Digital Eye-Tracking Device for Amblyopia Treatment Achieved Significantly Greater Visual Acuity Gains in Per-Protocol AnalysisAIRPORT CITY,...
NEW YORK, Sept. 3, 2024 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP) that centralizes and simplifies communication for...
ILLUMINÉ™ Harnesses the Power of Community to Build Privacy-first, Persona-Based Media Solutions PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- Health Union,...
To comply with academic institution guidelines, the founders' academic affiliations and roles are listed only at the end of the...
New Research and Case Studies Demonstrate Effectiveness of Machine Learning-Based Platforms for Adaptive Clinical Trial Design and Analysis BOSTON, Sept....
Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to...
ALBANY, NY / ACCESSWIRE / September 3, 2024 / Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased...
Regulatory approval enables entry of Auryon Atherectomy System in European marketLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative...
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...